Photo from The Mark Foundation for Cancer Research / Twitter
Aug 11, 2023, 15:20
Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion – The Mark Foundation for Cancer Research
Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion. We are proud to be a major sponsor of this work with a Mark Foundation ASPIRE award led by Jun Wang and Iannis Aifantis.
Out today Cell our latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. A great collaboration with Jun Wang and NYU Grossman School of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19